LV11027B - Aromatase inhibiting 4(5)-imidazoles aromatase inhibiting 4(5)-imidazoles - Google Patents

Aromatase inhibiting 4(5)-imidazoles aromatase inhibiting 4(5)-imidazoles Download PDF

Info

Publication number
LV11027B
LV11027B LVP-95-273A LV950273A LV11027B LV 11027 B LV11027 B LV 11027B LV 950273 A LV950273 A LV 950273A LV 11027 B LV11027 B LV 11027B
Authority
LV
Latvia
Prior art keywords
imidazole
acid addition
pharmaceutically acceptable
addition salt
acceptable acid
Prior art date
Application number
LVP-95-273A
Other languages
English (en)
Latvian (lv)
Other versions
LV11027A (lv
Inventor
Arto Johannes Karjalainen
Reino Olavi Pelkonen
Marja-Liisa Soedervall
Matti Antero Laehde
Risto Arvo Sakari Lammintausta
Arja Leena Karjalainen
Arja Marketta Kalapudas
Original Assignee
Orion Yhtyma Oy Orion Yhtyma O
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB8907218A external-priority patent/GB2229719B/en
Priority claimed from GB8907309A external-priority patent/GB2231568B/en
Application filed by Orion Yhtyma Oy Orion Yhtyma O filed Critical Orion Yhtyma Oy Orion Yhtyma O
Publication of LV11027A publication Critical patent/LV11027A/xx
Publication of LV11027B publication Critical patent/LV11027B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Epoxy Resins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Ceramic Products (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
LVP-95-273A 1989-03-30 1995-09-07 Aromatase inhibiting 4(5)-imidazoles aromatase inhibiting 4(5)-imidazoles LV11027B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8907218A GB2229719B (en) 1989-03-30 1989-03-30 Novel aromatase inhibiting 4(5)-imidazoles
GB8907309A GB2231568B (en) 1989-03-31 1989-03-31 New aromatase inhibiting 4(5)-imidazoles

Publications (2)

Publication Number Publication Date
LV11027A LV11027A (lv) 1996-02-20
LV11027B true LV11027B (en) 1996-08-20

Family

ID=26295152

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-95-273A LV11027B (en) 1989-03-30 1995-09-07 Aromatase inhibiting 4(5)-imidazoles aromatase inhibiting 4(5)-imidazoles

Country Status (19)

Country Link
EP (1) EP0390558B1 (pl)
JP (1) JPH032168A (pl)
CN (2) CN1046527A (pl)
AT (1) ATE111084T1 (pl)
AU (1) AU627559B2 (pl)
CZ (1) CZ281611B6 (pl)
DE (1) DE69012184T2 (pl)
DK (1) DK0390558T3 (pl)
ES (1) ES2063260T3 (pl)
HU (2) HU206685B (pl)
IE (1) IE64655B1 (pl)
IL (1) IL93940A (pl)
LV (1) LV11027B (pl)
NO (1) NO172797C (pl)
NZ (1) NZ233127A (pl)
PL (1) PL162513B1 (pl)
PT (1) PT93606B (pl)
RU (1) RU1836354C (pl)
UA (1) UA13471A (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2210875B (en) 1987-10-09 1991-05-29 Farmos Oy Aromatase inhibiting 4(5)-imidazoles
GB2229719B (en) 1989-03-30 1992-04-29 Farmos Oy Novel aromatase inhibiting 4(5)-imidazoles
GB2248058B (en) * 1990-09-21 1994-09-14 Orion Yhtymae Oy Aromatase inhibiting 4(5)-imidazoles
GB9125924D0 (en) * 1991-06-18 1992-02-05 Orion Yhtymae Oy Stereoisomers of an imidazole derivative
GB2273704B (en) * 1992-12-16 1997-01-22 Orion Yhtymae Oy Triazolyl diaryl selective aromatase inhibiting compounds
US7902247B2 (en) * 2008-01-09 2011-03-08 Allergan, Inc. Substituted-aryl-2-phenylethyl-1H-imidazole compounds as subtype selective modulators of alpha 2B and/or alpha 2C adrenergic receptors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2092569B (en) * 1981-02-05 1984-09-19 Farmos Oy Substituted imidazole derivatives and their preparation and use
GB2110663B (en) * 1981-12-04 1985-08-07 Farmos Group Ltd Imidazole derivatives
LU85747A1 (fr) * 1985-01-28 1986-08-04 Continental Pharma Derives d'imidazole leur preparation et utilisation ainsi que les compositions pharmaceutiques contenant des derives
GB2210875B (en) * 1987-10-09 1991-05-29 Farmos Oy Aromatase inhibiting 4(5)-imidazoles

Also Published As

Publication number Publication date
HU901894D0 (en) 1990-08-28
NZ233127A (en) 1991-03-26
IE64655B1 (en) 1995-08-23
AU627559B2 (en) 1992-08-27
AU5232590A (en) 1990-10-04
HU205345B (en) 1992-04-28
UA13471A (uk) 1997-02-28
CN1086812A (zh) 1994-05-18
HUT53357A (en) 1990-10-28
DK0390558T3 (da) 1994-10-10
EP0390558B1 (en) 1994-09-07
PT93606B (pt) 1996-08-30
DE69012184D1 (de) 1994-10-13
NO901451L (no) 1990-10-01
PL284552A1 (en) 1991-07-29
HU206685B (en) 1992-12-28
CZ281611B6 (cs) 1996-11-13
DE69012184T2 (de) 1995-01-05
EP0390558A1 (en) 1990-10-03
RU1836354C (ru) 1993-08-23
NO172797C (no) 1993-09-08
CZ155590A3 (en) 1996-08-14
ATE111084T1 (de) 1994-09-15
LV11027A (lv) 1996-02-20
HU914010D0 (en) 1992-03-30
ES2063260T3 (es) 1995-01-01
IL93940A0 (en) 1990-12-23
PT93606A (pt) 1990-11-20
JPH032168A (ja) 1991-01-08
IL93940A (en) 1994-10-07
IE901152L (en) 1990-09-30
NO172797B (no) 1993-06-01
PL162513B1 (pl) 1993-12-31
NO901451D0 (no) 1990-03-29
CN1046527A (zh) 1990-10-31

Similar Documents

Publication Publication Date Title
CA2105867C (en) Novel imidazole derivatives, their preparation and therapeutic applications
RU1819263C (ru) Способ получени замещенных имидазолов или их нетоксичных фармацевтически приемлемых аддитивных солей
RU1819264C (ru) Способ получени 2,4-диамино-5-(замещенных) пиримидинов
US4584383A (en) Substituted 2-mercapto-imidazoles and their preparation
US3940415A (en) 1-(Imidazolyl-1)-2-aryloxy-3-hydroxy-alkanes
CA1273942A (en) Derivatives of imidazole, their preparation and utilisation, and pharmaceutical compositions containing these derivatives
RO113986B1 (ro) Derivati de 4-cianofenil si procedeu de preparare a acestora
LV11027B (en) Aromatase inhibiting 4(5)-imidazoles aromatase inhibiting 4(5)-imidazoles
CA2111469A1 (en) New selective aromatase inhibiting 4(5)-imidazoles
KR20130131407A (ko) 2-(트리아지닐카르보닐) 술폰아닐리드의 제조 방법
CA1150279A (en) Triazolyl-alkene derivatives, a process for their preparation and their use as fungicides
Machin et al. . beta. 1-Selective adrenoceptor antagonists. 3. 4-Azolyl linked phenoxypropanolamines
US5439928A (en) Aromatase inhibiting 4(5)-imidazoles
CA2013395A1 (en) Aromatase inhibiting 4(5)-imidazoles
CA2051803A1 (en) Aromatase inhibiting 4(5)-imidazoles
PL162555B1 (pl) Sposób wytwarzania nowych pochodnych imidazolu PL
DE3310197A1 (de) Substituierte 3-mercapto-pyridazine und deren 3-alkylthioderivate sowie verfahren zu ihrer herstellung
JPS6272687A (ja) 新規イミダゾ−ル化合物及びその製造方法